BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arpadi SM, Shiau S, De Gusmao EP, Violari A. Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities. J Int AIDS Soc 2017;20 Suppl 7. [PMID: 29171190 DOI: 10.1002/jia2.25001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 El-Sadr WM, Rabkin M, Nkengasong J, Birx DL. Realizing the potential of routine viral load testing in sub-Saharan Africa. J Int AIDS Soc 2017;20 Suppl 7. [PMID: 29130621 DOI: 10.1002/jia2.25010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
2 Baptiste SL, Taro TB, Etya'ale HM. Community and activists demand for tenofovir/emtricitabine or lamivudine/dolutegravir and routine viral load testing. Curr Opin HIV AIDS 2019;14:7-12. [PMID: 30451698 DOI: 10.1097/COH.0000000000000515] [Reference Citation Analysis]
3 Shiferaw MB, Endalamaw D, Hussien M, Agegne M, Amare D, Estifanos F, Temesgen D. Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia. BMC Infect Dis 2019;19:419. [PMID: 31088496 DOI: 10.1186/s12879-019-4058-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Njom-Nlend AE, Efouba N, Brunelle Sandie A, Fokam J. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon. Trop Med Int Health 2021;26:927-35. [PMID: 33905593 DOI: 10.1111/tmi.13595] [Reference Citation Analysis]
5 van Liere GAFS, Lilian R, Dunlop J, Tait C, Rees K, Mabitsi M, Ranoto L, Struthers HE, McIntyre JA, Peters RPH. High rate of loss to follow-up and virological non-suppression in HIV-infected children on antiretroviral therapy highlights the need to improve quality of care in South Africa. Epidemiol Infect 2021;149:e88. [PMID: 33745490 DOI: 10.1017/S0950268821000637] [Reference Citation Analysis]
6 Fenta DA, Wube TB, Nuru MM. Long-Term Immunological and Virological Outcomes in Children Receiving Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia. J Immunol Res 2021;2021:2498025. [PMID: 33928167 DOI: 10.1155/2021/2498025] [Reference Citation Analysis]
7 Edessa D, Sisay M, Asefa F. Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One 2019;14:e0220159. [PMID: 31356613 DOI: 10.1371/journal.pone.0220159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
8 Arpadi SM, Shiau S, De Gusmao EP, Violari A. Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities. J Int AIDS Soc 2017;20 Suppl 7. [PMID: 29171190 DOI: 10.1002/jia2.25001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]